厄达替尼进国内2021医保了吗？厄达替尼多少钱一盒？

Erdafitinib, trade name Balversa, was approved by the US FDA on April 12, 2019, for the treatment of patients with locally advanced or metastatic bladder cancer who have FGFR3 or FGFR2 gene mutations and have progressed during or after platinum-containing chemotherapy, including patients with disease progression within 12 months of neoadjuvant or adjuvant platinum chemotherapy. For different types of genetic mutations, the therapeutic effects are different. For patients with FGFR3 point mutations, the objective response rate ORR after treatment is 40.6%; for patients with FGFR3 fusion mutations, the objective response rate ORR is 11.1%; and for patients with FGFR2 fusion mutations, the ORR is 0%, which means the treatment is ineffective.

Has erdafitinib been included in China’s 2021 medical insurance? How much does a box of erdafitinib cost? Erdafitinib is currently not approved for marketing in mainland China, so patients cannot purchase the drug domestically, but it is available in Hong Kong. Since this product has not yet been marketed in mainland China, there is no question of whether it will be included in the national medical insurance. However, I believe that erdafitinib will be launched in mainland China in the near future, bringing hope to domestic adult patients with locally advanced or metastatic urothelial cancer. Although erdafitinib is not on the market, the disease is at the forefront and medication is urgent. When most people can only spend a lot of manpower and material resources traveling domestically and abroad to purchase medicines, you may wish to find domestic and overseas medical institutions to help you purchase erdafitinib. According to Medical Companion Travel, Janssen exports Erdafitinib to Hong Kong in 4mg*28 capsules and the price is about $106,500, which is convenient, worry-free and cost-effective. Since the market price of drugs is determined based on the rise and fall of the exchange rate, the specific price is not static. You are welcome to contact Medical Companions at any time for more information about erdafitinib.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.